Recent Advances in the Management of Infections in Liver Transplant Recipients

Area of Science:

• Transplant Infectious Diseases
• Microbiology
• Virology

Background:

• Liver transplant recipients are increasingly susceptible to multidrug-resistant bacterial pathogens, including vancomycin-resistant enterococci and Staphylococcus aureus.
• These patients exhibit heightened vulnerability to harboring extended-spectrum beta-lactamase-producing Enterobacteriaceae.
• Mycelial fungal infections are rising, yet effective prophylaxis and management remain challenging.

Purpose of the Study:

• To review the spectrum of emerging infectious threats in liver transplant recipients.
• To highlight challenges in managing resistant bacterial, fungal, and viral infections.
• To discuss the clinical implications of antimicrobial and antiviral resistance in this population.

Main Methods:

• Literature review of recent studies and reports on infections in liver transplant recipients.
• Analysis of pathogen prevalence, focusing on antimicrobial resistance patterns.
• Examination of emerging viral threats and resistance mechanisms.

Main Results:

• Antimicrobial-resistant bacteria are leading causes of infection post-liver transplant.
• Increased incidence of fungal infections with suboptimal treatment outcomes.
• Emergence of novel herpesviruses and ganciclovir-resistant cytomegalovirus pose significant threats.

Conclusions:

• Liver transplant recipients are at high risk for diverse and resistant infections.
• Effective management strategies for fungal and viral infections, particularly resistant cytomegalovirus, are urgently needed.
• Continuous surveillance and development of novel therapeutic approaches are critical for improving outcomes in liver transplant recipients.